Related Experiment Video
Updated: Aug 19, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
[Contrast agents in MRT. Substance, effects, pharmacology and validity]
1Zentralinstitut für Bildgebende Diagnostik, Klinikum Karlsruhe. Peter.Reimer@klinik.uni-karlsruhe.de
Abstract:
The use of intravenous contrast agents in magnetic resonance imaging (MRI) has become well established clinical practice. Contrast agents provide additional information in many applications. Gadolinium chelates constitute the largest group of MR contrast agents and are considered to be safe. Different groups of contrast agents are established for clinical application: low concentrated gadolinium chelates, high concentrated gadolinium chelates, superparamagnetic iron oxide particles and hepatobiliary contrast agents. The review discusses the clinical applications and the safety issues involved with administration of intravenous contrast agents in MR imaging. Several approaches of intravascular or blood pool agents are also presented.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Related Concept Videos
Magnetic Resonance Imaging
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography